Cargando…
Repurposing the anti-malarial drug, quinacrine: new anti-colitis properties
BACKGROUND: Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is associated with an increased risk of colorectal cancer in 8-10 years after disease onset. Current colitis treatment strategies do not offer a cure for the disease, but only treat the symptoms with limited success and...
Autores principales: | Chumanevich, Alexander A., Witalison, Erin E., Chaparala, Anusha, Chumanevich, Anastasiya, Nagarkatti, Prakash, Nagarkatti, Mitzi, Hofseth, Lorne J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288159/ https://www.ncbi.nlm.nih.gov/pubmed/27447967 http://dx.doi.org/10.18632/oncotarget.10608 |
Ejemplares similares
-
Looking for the best anti-colitis medicine: A comparative analysis of current and prospective compounds
por: Chumanevich, Anastasiya A., et al.
Publicado: (2016) -
Molecules from American Ginseng Suppress Colitis through Nuclear Factor Erythroid-2-Related Factor 2
por: Chaparala, Anusha, et al.
Publicado: (2020) -
Pharmacokinetics of Panaxynol in Mice
por: Tashkandi, Hossam, et al.
Publicado: (2020) -
Panaxynol, a bioactive component of American ginseng, targets macrophages and suppresses colitis in mice
por: Chaparala, Anusha, et al.
Publicado: (2020) -
A Limited Role of p53 on the Ability of a Hexane Fraction of American Ginseng to Suppress Mouse Colitis
por: Poudyal, Deepak, et al.
Publicado: (2012)